Researchers at Stanford University have developed a new type of cancer therapy. The technology targets mucins, sugar-coated proteins that help cancer cells to metastasize and avoid the immune system. In particular, mucins enable cancer…
Continue Reading
CAR T-cell therapy is used to treat patients with blood cancers such as multiple myeloma. Since it can cause serious side effects, patients are usually hospitalized and monitored for up to two weeks after…
Continue Reading
What You Should Know:
Recently, researchers from Chung-Ang University developed an electrochemical DNA biosensor with enhanced sensitivity for effective HPV detection with high specificity.They achieved this feat using a graphitic nano-onion/molybdenum disulfide nanosheet composite with…
Continue Reading
What You Should Know:
Ibex Medical Analytics launches Galen Breast HER2™, a novel breast cancer AI-powered biomarker scoring solution developed in collaboration with AstraZeneca and Daiichi Sankyo, to support improved patient outcomes.Galen Breast HER2 is an AI-powered biomarker…
Continue Reading
What You Should Know: Flatiron Health today announced its renewed collaboration with the Oncology Center of Excellence (OCE) of FDA to jointly develop and implement specific research projects to advance the use of Real World…
Continue Reading
What You Should Know: – Ibex Medical Analytics (Ibex), a provider of AI-powered cancer diagnostics raises $55M in Series C financing round led by 83North. – The round also included participation from Sienna Venture Capital and existing…
Continue Reading
E-pharmacy MrMed scores half mil for expansionOnline pharmacy MrMed has raised $500,000 from a funding round led by the Tamil Nadu Emerging Sector Seed Fund.
According to a news report, the company will use its…
New research by the University of Cincinnati Cancer Center and Cincinnati Children’s Hospital Medical Center highlights the influence of timing intervals on skin preservation in FLASH proton therapy. Published in the International Journal of…
Continue Reading
What You Should Know:
DoMore Diagnostics, a leader in deep learning precision diagnostics for digital pathology, and Proscia®, a leading provider of digital and computational pathology solutions, have partnered to help pathologists predict outcomes for colorectal cancer…
Continue Reading
Prostate Cancer Research (PCR) has received sponsorship to support its first of its kind prostate cancer patient data platform and virtual registry.The project, which is supported by IQVIA and sponsored by Bayer and Advanced…
Continue Reading
